Skip to main content
. 2022 Sep;11(5):525–532. doi: 10.21037/acs-2022-rmvs-73

Table 5. Postoperative morbidity.

Morbidity N=200
Reoperation for bleeding, n (%) 2 (1.0)
Postoperative stroke, n (%) 1 (0.5)
Prolonged pulmonary ventilation, n (%) 6 (3.0)
Pneumonia, n (%) 2 (1.0)
Deep venous thrombosis, n (%) 1 (0.5)
Pleural effusion, n (%) 4 (2.0)
Pneumothorax, n (%) 5 (2.5)
Renal failure, n (%) 2 (1.0)
Pacemaker implantation, n (%) 2 (1.0)
Postoperative atrial fibrillation, n (%) 48 (24.0)
Length of stay, days 4 [3–6]
30–day mortality, n (%) 1 (0.5)
30-day readmission, n (%) 27 (13.5)
   Arrhythmia/heart block 12 (6.0)
   Chest pain (non-cardiac) 2 (1.0)
   Congestive heart failure 1 (0.5)
   Mental status changes 1 (0.5)
   Pericarditis 1 (0.5)
   Pleural effusion requiring drainage 4 (2.0)
   Other (non-cardiac-related) 6 (3.0)